Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Healthcare Services (HCSG) Shares Outstanding (Weighted Average) (2016 - 2026)

Healthcare Services has reported Shares Outstanding (Weighted Average) over the past 18 years, most recently at $69.9 million for Q1 2026.

  • Quarterly Shares Outstanding (Weighted Average) fell 5.17% to $69.9 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $69.9 million through Mar 2026, down 5.17% year-over-year, with the annual reading at $72.4 million for FY2025, 1.86% down from the prior year.
  • Shares Outstanding (Weighted Average) was $69.9 million for Q1 2026 at Healthcare Services, down from $72.4 million in the prior quarter.
  • Over five years, Shares Outstanding (Weighted Average) peaked at $74.5 million in Q1 2023 and troughed at $69.9 million in Q1 2026.
  • The 5-year median for Shares Outstanding (Weighted Average) is $73.9 million (2024), against an average of $73.7 million.
  • Biggest five-year swings in Shares Outstanding (Weighted Average): grew 0.23% in 2023 and later decreased 5.17% in 2026.
  • Tracing HCSG's Shares Outstanding (Weighted Average) over 5 years: stood at $74.3 million in 2022, then dropped by 0.06% to $74.3 million in 2023, then fell by 0.72% to $73.8 million in 2024, then fell by 1.86% to $72.4 million in 2025, then decreased by 3.48% to $69.9 million in 2026.
  • According to Business Quant data, Shares Outstanding (Weighted Average) over the past three periods came in at $69.9 million, $72.4 million, and $73.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.